Publication | Closed Access
A randomized trial of <i>Lactobacillus rhamnosus</i> IDCC 3201 tyndallizate (RHT3201) for treating atopic dermatitis
76
Citations
15
References
2020
Year
In children with moderate AD, oral administration of RHT3201 showed the therapeutic effect on AD, the effects in part correlated with decrement of ECP and IL-31, and the effect was more remarkable in subgroup analysis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1